Skip to content

Effect of dexmedetomidine on kidney function after cardiopulmonary bypass via the early predictive biomarkers

Effect of dexmedetomidine on kidney function after cardiopulmonary bypass via the early predictive biomarkers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001288
Enrollment
Unknown
Registered
2011-03-18
Start date
2011-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adult acute kidney imparement after cardiopulmonarybypass

Interventions

control group:the patients of control group will be administrated saline the same way as the dexmedetomidine
dexmedetomidine group:Patients of dexmedetomidine group will be administrated initial dose of dexmedetomidine (0.5ug /kg) pump over 10 min 30 minutes before induction of anesthesia, subsequently recei

Sponsors

Nanjing First Hospital affiliated to Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. patients whose ASA are within I-III; 2. adult subjects scheduled to undergo cardiac surgery under cardiopulmonary bypass; 3. Patients who signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant women; 2. patients who received long-term dialysis; 3. patients who received acute dialysis before surgery; 4. patients who received organ transplantation within the last year.

Design outcomes

Primary

MeasureTime frame
urinary KIM-1;serum NGAL, urinary NGAL;urinary L-FABP;serum Cys C;

Secondary

MeasureTime frame
serum albumin, serum BUN, serum Cr, Glu, serum beta 2 microprotein, serum uric acid;

Countries

China

Contacts

Public ContactHongguang Bao
hongguang_bao@hotmail.com+86 025 52271032

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026